These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32656246)

  • 1. Meta-Analysis Comparing Watchman
    Basu Ray I; Khanra D; Shah S; Char S; Jia X; Lam W; Mathuria N; Razavi M; Jain B; Lakkireddy D; Kar S; Natale A; Adeboye A; Jefferies JL; Bangalore S; Asirvatham S; Saeed M
    Front Cardiovasc Med; 2020; 7():89. PubMed ID: 32656246
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience.
    Saad M; Risha O; Sano M; Fink T; Heeger CH; Vogler J; Sciacca V; Eitel C; Stiermaier T; Joost A; Keelani A; Fuernau G; Meyer-Saraei R; Kuck KH; Eitel I; Richard Tilz R
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100893. PubMed ID: 34712772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort Study.
    Kayvanpour E; Kothe M; Kaya Z; Pleger S; Frey N; Meder B; Sedaghat-Hamedani F
    J Cardiovasc Dev Dis; 2024 May; 11(6):. PubMed ID: 38921657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Gambhir A; Hermiller J; Nielsen-Kudsk JE; Worthley S; Nair D; Schmidt B; Horton R; Gupta N; Anderson JA; Gage R; Alkhouli M; Windecker S
    JACC Cardiovasc Interv; 2023 Aug; 16(15):1902-1913. PubMed ID: 37587599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation.
    Sick PB
    J Atr Fibrillation; 2013; 6(3):923. PubMed ID: 28496896
    [No Abstract]   [Full Text] [Related]  

  • 15. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.
    Saw J; Fahmy P; DeJong P; Lempereur M; Spencer R; Tsang M; Gin K; Jue J; Mayo J; McLaughlin P; Nicolaou S
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1198-206. PubMed ID: 25851318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.